Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise Nott

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Clinical Colorectal Cancer|September 13, 2020
Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance StatusAvraham Travers, Azim Jalali, Stephen Begbie, et al.
Clinical Colorectal Cancer|March 13, 2016
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal CancerHui-Li Wong, Belinda Lee, Kathryn Field, et al.
The Oncologist|April 3, 2019
Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric CancerAnuradha Vasista, Martin Stockler, Andrew Martin, et al.
Internal Medicine Journal|October 28, 2024
Medicine Access Programmes: what do patients think - a patient-reported outcome study on ribociclib in metastatic breast cancer in AustraliaNatasha Yap, Vanessa Wong, Catherine Morton, et al.
Asia-Pacific Journal of Clinical Oncology|November 26, 2016
The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort studyBelinda Lee, Hui-Li Wong, Mark Tacey, et al.
Current Problems in Cancer|August 23, 2020
Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancerThiru Prasanna, Rachel Wong, Timothy Price, et al.
Internal Medicine Journal|November 18, 2024
Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancerMatthew Loft, Vanessa Wong, Suzanne Kosmider, et al.
Asia-Pacific Journal of Clinical Oncology|January 24, 2022
Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancerChia Yuen Chong, Azim Jalali, Hui Li Wong, et al.
Clinical Colorectal Cancer|November 10, 2024
Initial Assessment of Resectability of Colorectal Cancer Liver Metastases Versus Clinical OutcomeGrace Y Kim, Azim Jalali, Grace Gard, et al.
The Oncologist|March 11, 2022
Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical TrialsJ Connor Wells, Aven Sidhu, Keyue Ding, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Clinical Colorectal Cancer|September 13, 2020
Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance StatusAvraham Travers, Azim Jalali, Stephen Begbie, et al.
Clinical Colorectal Cancer|March 13, 2016
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal CancerHui-Li Wong, Belinda Lee, Kathryn Field, et al.
The Oncologist|April 3, 2019
Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric CancerAnuradha Vasista, Martin Stockler, Andrew Martin, et al.
Internal Medicine Journal|October 28, 2024
Medicine Access Programmes: what do patients think - a patient-reported outcome study on ribociclib in metastatic breast cancer in AustraliaNatasha Yap, Vanessa Wong, Catherine Morton, et al.
Asia-Pacific Journal of Clinical Oncology|November 26, 2016
The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort studyBelinda Lee, Hui-Li Wong, Mark Tacey, et al.
Current Problems in Cancer|August 23, 2020
Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancerThiru Prasanna, Rachel Wong, Timothy Price, et al.
Internal Medicine Journal|November 18, 2024
Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancerMatthew Loft, Vanessa Wong, Suzanne Kosmider, et al.
Asia-Pacific Journal of Clinical Oncology|January 24, 2022
Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancerChia Yuen Chong, Azim Jalali, Hui Li Wong, et al.
Clinical Colorectal Cancer|November 10, 2024
Initial Assessment of Resectability of Colorectal Cancer Liver Metastases Versus Clinical OutcomeGrace Y Kim, Azim Jalali, Grace Gard, et al.
The Oncologist|March 11, 2022
Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical TrialsJ Connor Wells, Aven Sidhu, Keyue Ding, et al.
Pageof 6